Evidence map›Paper›PMID 28766244›Full record

ReviewDigestive diseases and sciences2017

Sulfur Cycling and the Intestinal Microbiome.

Larry L Barton, Nathaniel L Ritz, Guy D Fauque, Henry C Lin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Digestive diseases and sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Significance of GSH and HRedox report : communications in free radical research · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Advances in microbial sulfoquinovose catabolism.Frontiers in microbiology · 2026
    Review
  9. Power and poison: The intersections of HThe Journal of biological chemistry · 2025
    Review
  10. Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  11. Review
  12. Article
  13. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Microbial metabolism of host-derived antioxidants.Current opinion in chemical biology · 2025
    Review
  18. Diversity and ecology of microbial sulfur metabolism.Nature reviews. Microbiology · 2025
    Review
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Larry L BartonDepartment of Biology, MSCO3 2020, University of New Mexico, Albuquerque, NM, 87131, USA. lbarton@unm.edu.
Nathaniel L RitzNew Mexico VA Health Care System, University of New Mexico, Albuquerque, NM, 87131, USA.
Guy D FauqueCNRS, IRD, Mediterranean Institute of Oceanography (MIO) UM 110, Aix-Marseille Université, Université de Toulon, Campus de Luminy, Case 901, 13288, Marseille Cedex 09, France.
Henry C LinNew Mexico VA Health Care System, University of New Mexico, Albuquerque, NM, 87131, USA.
New Mexico VA Health Care System · USCentre National de la Recherche Scientifique · FRUniversity of New Mexico · US

Funding

Winkler Bacterial Overgrowth Research Fund BRINM-217
6 · The paper itself

Abstract

In this review, we focus on the activities transpiring in the anaerobic segment of the sulfur cycle occurring in the gut environment where hydrogen sulfide is produced. While sulfate-reducing bacteria are considered as the principal agents for hydrogen sulfide production, the enzymatic desulfhydration of cysteine by heterotrophic bacteria also contributes to production of hydrogen sulfide. For sulfate-reducing bacteria respiration, molecular hydrogen and lactate are suitable as electron donors while sulfate functions as the terminal electron acceptor. Dietary components provide fiber and macromolecules that are degraded by bacterial enzymes to monomers, and these are fermented by intestinal bacteria with the production to molecular hydrogen which promotes the metabolic dominance by sulfate-reducing bacteria. Sulfate is also required by the sulfate-reducing bacteria, and this can be supplied by sulfate- and sulfonate-containing compounds that are hydrolyzed by intestinal bacterial with the release of sulfate. While hydrogen sulfide in the intestinal biosystem may be beneficial to bacteria by increasing resistance to antibiotics, and protecting them from reactive oxygen species, hydrogen sulfide at elevated concentrations may become toxic to the host.

Indexed as

AnimalsAnti-Bacterial AgentsDrug Resistance, BacterialGastrointestinal MicrobiomeHumansHydrogen SulfideSulfurAnti-Bacterial AgentsHydrogen SulfideSulfurAntibiotic resistanceGut bacteriaSulfate-reducing bacteriaSulfide production

Identifiers

PMID28766244
OpenAlexW2741474637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.